Cargando…

Trabectedin as a single agent and in combination with pegylated liposomal doxorubicin – activity against ovarian cancer cells

Over 225 000 new cases of ovarian cancer are diagnosed each year. Symptoms are often vague, so most cases are detected when the disease is at an advanced stage. There is a need to find new drugs which will be able to treat ovarian cancer effectively. One of the most promising antineoplastic agents i...

Descripción completa

Detalles Bibliográficos
Autores principales: Marczak, Agnieszka, Denel, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268992/
https://www.ncbi.nlm.nih.gov/pubmed/25520572
http://dx.doi.org/10.5114/wo.2014.43153

Ejemplares similares